Artrofoon, tablets 100 pcs

Pharmacological properties

Pharmacodynamics

It was experimentally and clinically proved that the preparation modulates the production and functional activity of endogenous tumor necrosis factor alpha (TNFα) in rheumatoid arthritis, osteoarthritis, osteochondrosis, back pain; nonspecific ulcerative colitis (NUC). It has anti-inflammatory and analgesic effect.

By reducing the number of pro-inflammatory cytokines and inflammatory mediators it prevents the progression of inflammatory damages of tissues and target organs in inflammatory and degenerative joint diseases and IPP.

Pharmacokinetics

The sensitivity of modern physico-chemical methods of analysis (gas-liquid chromatography, high-performance liquid chromatography, chromato-mass spectrometry) does not allow evaluating the ultra-low doses of antibodies in biological fluids, organs and tissues, which makes it technically impossible to study the pharmacokinetics of the drug Artrofoon.

Indications

Rheumatoid arthritis, osteoarthritis (including spondyloarthritis) and other joint diseases. During remission period the drug may be used in monotherapy; during acute conditions it may be used as part of complex therapy (with nonsteroidal anti-inflammatory drugs).

Nonspecific ulcerative colitis of mild to moderate severity.

Active ingredient

Composition

How to take, the dosage

Interaction

Incompatibilities with other drugs have not yet been registered.

The drug may be combined with nonsteroidal anti-inflammatory drugs.

Special Instructions

Synopsis

Contraindications

Side effects

Overdose

In case of accidental overdose, dyspeptic phenomena due to excipients included in the drug are possible.

Pregnancy use

Similarities